ELIGARD KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eligard Kit, and when can generic versions of Eligard Kit launch?
Eligard Kit is a drug marketed by Tolmar and is included in four NDAs. There is one patent protecting this drug.
This drug has eleven patent family members in eleven countries.
The generic ingredient in ELIGARD KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eligard Kit
A generic version of ELIGARD KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for ELIGARD KIT
International Patents: | 11 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 50 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ELIGARD KIT at DailyMed |
Recent Clinical Trials for ELIGARD KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eli Lilly and Company | Phase 1/Phase 2 |
Bayer | Phase 1/Phase 2 |
Praful Ravi | Phase 1/Phase 2 |
Pharmacology for ELIGARD KIT
Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
US Patents and Regulatory Information for ELIGARD KIT
ELIGARD KIT is protected by one US patents.
Patents protecting ELIGARD KIT
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ELIGARD KIT
International Patents for ELIGARD KIT
See the table below for patents covering ELIGARD KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2022137182 | ⤷ Try a Trial | |
Canada | 2117394 | ⤷ Try a Trial | |
Japan | 2014240439 | 改良された効力を備えた、ロイプロリドのポリマー送達処方物 (POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY) | ⤷ Try a Trial |
Czech Republic | 303134 | Polymerní formulace leuprolidu pro podání se zlepšenou úcinností (Leuprolide polymeric delivery formulation with improved efficacy) | ⤷ Try a Trial |
Luxembourg | 91193 | ⤷ Try a Trial | |
Spain | 2219079 | ⤷ Try a Trial | |
Iceland | 6794 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ELIGARD KIT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0436667 | 91193 | Luxembourg | ⤷ Try a Trial | 91193, EXPIRES: 20140927 |
0436667 | C300204 | Netherlands | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |